Abstract
Tanacetum parthenium Schulz-Bip, formerly Chrysanthemum parthenium (L.) Bernh, Leucanthemum parthenium (L.) Gren and Gordon, Pyrethum parthenium (L.) Sm; also described as a member of the genus Matricaria (Anonymous, 1994; USP, 1998a); featherfew, altamisa, bachelor’s button, featherfoil, febrifuge plant, midsummer daisy, nosebleed, Santa Maria, wild chamomile, wild quinine (Anonymous, 1994), amargosa, flirtwort, manzanilla, mutterkraut, varadika (USP, 1998a)
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson D, Jenkinson PC, Dewdney RS, Blowere SD, Johnson ES, Kadam NP. Chromosomal aberrations and sister chromatid exchanges in lymphocytes and urine mutagenicity of migraine patients: a comparison of chronic feverfew users and age matched nonusers. Hum Toxicol 1988; 7: 145–52.
Anonymous. Feverfew. The Lawrence review of natural products. St. Louis, MO: Facts and Comparisons, 1994.
Awang DVC. Feverfew fever. A headache for the consumer. HerbalGram 1993; 29: 346, 66.
Awang DVC, Dawson BA, Kindack DG, Heptinstall S. Parthenolide content of feverfew [Tanacetumparthenium (L.) Schultz-Bip.] assessed by HPLC and 1H-NMR spectroscopy. J Nat Prod 1991; 54: 1516–21.
Barsby RWJ, Knight DW, McFadzean I. A chloroform extract of the herb feverfew blocks voltage-dependent potassium currents recorded from single smooth muscle cells. J Pharm Pharmacol 1993a; 45: 641–5.
Barsby RWJ, Salan U, Knight DW, Hoult JRS. Feverfew and vascular smooth muscle: extracts from fresh and dried plants show opposing pharmacological profiles, dependent upon sesquiterpene lactone content. Planta Med 1993b; 59: 20–5.
Benner MH, Lee HJ. Anaphylactic reaction to chamomile tea. J Allergy Clin Immunol 1973; 52: 307–8.
Biggs MJ, Johnson ES, Persaud NP, Ratcliffe DM. Platelet aggregation in patients using feverfew for migraine. Lancet 1982; 2: 776.
Collier HOJ, Butt NM, McDonald-Gibson WJ, Saeed SA. Extract of feverfew inhibits prostaglandin biosynthesis. Lancet 1980; 2: 922–3.
DeWeerdt CJ, Bootsma HPR, Hendriks H. Herbal medicine in migraine prevention: randomized, double-blind, placebo-controlled crossover trial of a feverfew preparation. Phytomed 1996; 3: 225–30.
Dolman DM, Knight DW, Salan U, Toplis D. A quantitiative method for the estimation of parthenolide and other sesquiterpene lactones containing alphamethylenebutyrolactone functions present in feverfew, Tanacetum parthenium. Phytochem Anal 1992; 3: 26–31.
Groenewegen WA, Heptinstall S. Amounts of feverfew in commercial perparations of the herb. Lancet 1986; 1: 44–5.
Groenewegen WA, Heptinstall S. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in vitro. J Pharm Pharmacol 1990; 42: 553–57.
Hay AJB, Hamburger M, Hostettmann K, Hoult JRS. Toxic inhibition of smooth muscle contractility by plant-derived sesquiterpenes caused by their chemically reactive amethylenebutyrolactone functions. Br J Pharmacol 1994; 112: 9–12.
Heptinstall S, Awang DVC, Dawson BA, Kindack D, Knight DW, May J. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium [L.] schultz-Bip.). Estimation of commercial and authenticated feverfew products. J Pharm Pharmacol 1992; 44: 391–5.
Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J 1985; 291: 569–73.
Knight DW. Feverfew: chemistry and biological activity. Nat Prod Rep 1995; 12: 271–6.
Lee K, Huang E, Piantadosi C, Pagano JS, Geissman TA. Cytotoxicity of sesquiterpene lactones. Cancer Res 1971; 31: 1649–54.
Makheja AN, Bailey JM. The active principle in feverfew. Lancet 1981; 2: 1054.
Marles RJ, Kaminski J, Amason JT. A bioassay for the inhibition of serotonin release from bovine platelets. J Nat Prod 1992; 55: 1044–56.
Murch SJ, Simmons CB, Saxena PK. Melatonin in feverfew and other medicinal plants. Lancet 1997; 350: 1598–9.
Murphy JJ, Heptinstall S, Mitchell JRA. Randomized, double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988; 2: 189–92.
O’Neill LAJ, Barrett ML, Lewis GP. Extracts of feverfew inhibit mitogen-induced human peripheral blood mononuclear cell proliferation and cytokine mediated responses: a cytotoxic effect. Br J Clin Pharmacol 1987; 23: 81–3.
Palevitch D, Earon G, Carasso R. Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytother Res 1997; 11: 508–11.
Pattrick M, Heptinstall S, Doherty M. Feverfew in rheumatoid arthritis: a double blind, placebo controlled study. Ann Rheum Dis 1989; 48: 547–9.
Pickman AK, Huang ES, Piantidosi C, Pagano JS, Geissman TA. Visualisation reagents for sesquiterpene lactones and polyacetylenes on TLC. J Chromatogr 1980; 189: 187–98.
Tyler VE. The honest herbal. 3rd edit., Binghamton, NY: Pharmaceutical Products Press, 1993.
Tyler VE. Herbs of choice: the therapeutic use of phytomedicinals. Binghamton, NY: Pharmaceuticals Products Press, 1994.
United States Pharmacopeial Convention (USP). Feverfew. Botanical monograph series. Rockville, MD: United States Pharmacopeial Convention, 1998a.
United States Pharmacopoeia (USP). National Formulary. 18th edit., Suppl 9. Rockville, MD: United States Pharmacopeial Convention, 1998b.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schuller, B., Cupp, M.J. (2000). Feverfew. In: Cupp, M.J. (eds) Toxicology and Clinical Pharmacology of Herbal Products. Forensic Science and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-020-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-59259-020-9_9
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-190-5
Online ISBN: 978-1-59259-020-9
eBook Packages: Springer Book Archive